CRASTO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 269
EU - Europa 185
AS - Asia 81
AF - Africa 6
OC - Oceania 3
SA - Sud America 1
Totale 545
Nazione #
US - Stati Uniti d'America 268
CN - Cina 59
IT - Italia 54
AT - Austria 25
FR - Francia 23
IE - Irlanda 21
SE - Svezia 15
UA - Ucraina 14
VN - Vietnam 10
DE - Germania 7
FI - Finlandia 6
PL - Polonia 6
SN - Senegal 6
CH - Svizzera 4
CZ - Repubblica Ceca 4
GB - Regno Unito 4
JP - Giappone 4
AU - Australia 3
IL - Israele 3
IN - India 2
BR - Brasile 1
CA - Canada 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
NL - Olanda 1
TR - Turchia 1
Totale 545
Città #
Chandler 50
Beijing 42
Fremont 29
Vienna 23
Dublin 21
Torino 15
Villeurbanne 14
Ann Arbor 11
Dearborn 11
Nyköping 11
Wilmington 10
Medford 9
Fairfield 8
Houston 8
Pisa 8
Jacksonville 7
Princeton 6
Redwood City 6
Woodbridge 5
San Jose 4
San Mateo 4
Warsaw 4
Ashburn 3
Cambridge 3
Duncan 3
Hefei 3
Venice 3
Chengdu 2
Dong Ket 2
Düsseldorf 2
Fuzhou 2
Gdynia 2
Montigny-le-bretonneux 2
Nutley 2
Piossasco 2
Shanghai 2
Tel Aviv 2
Tianjin 2
Wuhan 2
Adelaide 1
Amsterdam 1
Basel 1
Boardman 1
Boston 1
Brescia 1
Bronx 1
Carol Stream 1
Central 1
Costa Mesa 1
Easton 1
Göttingen 1
Haifa 1
Izmir 1
Jakarta 1
Jersey City 1
Nanchang 1
Nanjing 1
New Haven 1
New York 1
Ningbo 1
Norwalk 1
Prague 1
Rome 1
Seattle 1
Sydney 1
São Paulo 1
Toronto 1
Turin 1
Venezia 1
Zurich 1
Totale 376
Nome #
Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes 184
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4 96
TFR2 AND EpoR EXPRESSION AT DIAGNOSIS AS POSSIBLE PREDICTORS OF ERYTHROPOIETIN TREATMENT RESPONSE IN MDS PATIENTS 92
EARLY BCR-ABL REDUCTION IS PREDICTIVE OF BETTER EVENT FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA NEWLY DIAGNOSED PATIENTS TREATED WITH ANY TKIS 75
Consistency Of RQPCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View 67
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor 59
Totale 573
Categoria #
all - tutte 957
article - articoli 0
book - libri 0
conference - conferenze 587
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1544


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201844 0000 00 00 34820
2018/201990 1793 71 311 516225
2019/202063 4638 314 90 5632
2020/202177 4831 141 72 411418
2021/202275 5214 21 82 333014
2022/2023117 1114225 825 614 12000
Totale 573